Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥7,056 | CN¥6,629 | CN¥7,560 | CN¥4,552 |
| - Cash | CN¥669 | CN¥754 | CN¥854 | CN¥918 |
| + Debt | CN¥484 | CN¥366 | CN¥459 | CN¥414 |
| Enterprise Value | CN¥6,870 | CN¥6,242 | CN¥7,165 | CN¥4,048 |
| Revenue | CN¥572 | CN¥638 | CN¥722 | CN¥858 |
| % Growth | -10.4% | -11.6% | -15.9% | – |
| Gross Profit | CN¥208 | CN¥245 | CN¥247 | CN¥344 |
| % Margin | 36.5% | 38.3% | 34.2% | 40.1% |
| EBITDA | -CN¥6 | CN¥13 | CN¥53 | CN¥155 |
| % Margin | -1.1% | 2% | 7.4% | 18.1% |
| Net Income | -CN¥12 | CN¥8 | CN¥35 | CN¥46 |
| % Margin | -2.1% | 1.3% | 4.9% | 5.3% |
| EPS Diluted | -0.031 | 0.021 | 0.09 | 0.12 |
| % Growth | -245.3% | -76.2% | -25% | – |
| Operating Cash Flow | CN¥80 | CN¥113 | -CN¥9 | CN¥95 |
| Capital Expenditures | -CN¥39 | -CN¥18 | -CN¥18 | -CN¥31 |
| Free Cash Flow | CN¥41 | CN¥95 | -CN¥26 | CN¥65 |